Iben Aagaard Christensen

Sr. Regulatory Affairs Specialist

Iben has more than 25 years of experience from the international pharmaceutical / biotech industry as well as the Danish Medicines Agency. Iben’s regulatory experience covers both the CMC, preclinical and clinical parts of the regulatory dossier as well as administrative aspects of submissions, in all phases from pre-phase 1 to LCM. Combined with her diploma in pharmaceutical product innovation, this allows her to maintain a holistic regulatory strategic perspective when engaged in preparing and reviewing regulatory documentation.

Iben has lead a global regulatory affairs team and secured development and execution of global regulatory strategies including strategy for In Vitro Diagnostic (IVD) for use in clinical trials and as companion diagnostic.